Issuers, get 33% more new shareholders with investorHub. Learn more
Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.0025
▾0.00 (0.00%)
Last trade: 01/06, 12:31PM
Market cap
$28.85m
Market closed
Investor Presentations
Principal Activity
Genetic Technologies Limited (GTG) is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The Company's lead product is BREVAGenplus.
Address
60-66 Hanover St, Fitzroy VIC 3065, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.0025
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia